Delivery Order SPE2DB20D9136-SPE2DB25FJ59P
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,744.37 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. This firm fixed-price delivery order, issued on August 19, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026. The delivery order specifies Park Ridge, Illinois as the place of performance, with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant product. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is headquartered. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency (DLA) awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 28, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The award carries no set-aside designation, and performance will be executed in Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The awardee, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- SPE2DB20D9136Indefinite Delivery Contract
- SPE2DB20D9136-SPE2DB25FJ59PDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order represents a relatively modest transaction within the broader pharmaceutical supply ecosystem. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting military health facilities worldwide, encompassing branded and generic prescription drugs, over-the-counter medications, biologics, and specialty medical consumables. As a woman-owned small business with decades of federal contracting experience, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution services to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/22/25 |